Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.

Conference item

Reperfusion therapy with tissue plasminogen activator (tPA) is a rational therapy for acute ischemic stroke. Properly titrated use of tPA improves clinical outcomes. However, there is also an associated risk of hemorrhagic transformation after tPA therapy. Emerging data now suggest that some of these potentially neurotoxic side effects of tPA may be due to its signaling actions in the neurovascular unit. Besides its intended role in clot lysis, tPA is also an extracellular protease and signaling molecule in brain. tPA mediates matrix remodeling during brain development and plasticity. By interacting with the NMDA-type glutamate receptor, tPA may amplify potentially excitotoxic calcium currents. At selected concentrations, tPA may be vasoactive. Finally, by augmenting matrix metalloproteinase (MMP) dysregulation after stroke, tPA may degrade extracellular matrix integrity and increase risks of neurovascular cell death, blood-brain barrier leakage, edema, and hemorrhage. Understanding these pleiotropic actions of tPA may reveal new therapeutic opportunities for combination stroke therapy.

Authors: Wang, X; Tsuji, K; Lee, SR; Ning, M; Furie, K

• Publication status: Published
• Host title: Stroke; a journal of cerebral circulation
• Volume: 35
• Issue: 11 Suppl 1
• Pages: 2726-2730
• Publication date: 2004-11-01
• Event location: United States
• DOI: 10.1161/01.str.0000143219.16695.af
• EISSN: 1524-4628
• ISSN: 0039-2499
• Keywords: Thrombolytic Therapy; Vasoconstriction; Animals; Plasminogen Activators; Cerebral Hemorrhage; Stroke; Brain; Humans; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Tissue Plasminogen Activator; Extracellular Matrix